Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

CDT | Conduit Pharmaceuticals Inc

Index- P/E218.55 EPS (ttm)0.02 Insider Own65.30% Shs Outstand13.98M Perf Week-26.37%
Market Cap30.19M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.17M Perf Month-54.78%
Income0.55M PEG- EPS next Q- Inst Own25.31% Short Float / Ratio0.17% / 0.05 Perf Quarter-53.82%
Sales0.00M P/S- EPS this Y- Inst Trans1.29% Short Interest0.00M Perf Half Y-52.51%
Book/sh2.73 P/B1.77 EPS next Y- ROA0.68% Target Price- Perf Year-
Cash/sh0.04 P/C107.81 EPS next 5Y- ROE0.73% 52W Range5.07 - 25.00 Perf YTD-52.88%
Dividend- P/FCF- EPS past 5Y- ROI3.21% 52W High-80.68% Beta0.35
Dividend %- Quick Ratio0.17 Sales past 5Y0.00% Gross Margin- 52W Low-4.73% ATR2.37
Employees3 Current Ratio0.17 Sales Q/Q- Oper. Margin0.00% RSI (14)31.50 Volatility23.64% 22.81%
OptionableNo Debt/Eq0.04 EPS Q/Q-708.82% Profit Margin- Rel Volume0.27 Prev Close6.03
ShortableYes LT Debt/Eq0.00 Earnings- Payout0.00% Avg Volume80.38K Price4.83
Recom- SMA20-54.14% SMA50-54.64% SMA200-53.20% Volume21,757 Change-19.90%
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships. Its medical needs in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heilbron Jack KendrickFormer CEO,director&10% ownerSep 22Option Exercise0.004,060,25004,060,250Sep 26 05:30 PM